Найкращі лікарі з кольпоскопії в Шанхай – ТОП-2 лікарі

Dr. Wu Sufang is a distinguished Professor and Chief Physician, currently serving as the Director of the Department of Obstetrics and Gynecology at a leading tertiary hospital in China. Her exceptional career spans over three decades of frontline clinical work, during which she has established herself as a national authority in the management of gynecologic malignancies.

Dr. Wu’s academic journey began with rigorous training under the mentorship of Academician Martin, a globally recognized pioneer in gynecologic oncology. This early exposure to cutting-edge research and clinical excellence laid a solid foundation for her future endeavors. She further advanced her expertise through postdoctoral research at the renowned MD Anderson Cancer Center in the United States, one of the world’s top institutions for cancer care. There, she gained invaluable insights into molecular mechanisms of tumor progression and novel therapeutic strategies, which she later integrated into her own clinical and research practice.

Clinically, Dr. Wu specializes in radical surgeries for gynecologic cancers, including but not limited to radical hysterectomy for cervical cancer, cytoreductive surgery for ovarian cancer, and comprehensive staging procedures for endometrial cancer. She is particularly adept at performing complex pelvic and para-aortic lymphadenectomies, fertility-sparing surgeries for early-stage malignancies, and minimally invasive approaches when appropriate. Beyond surgery, Dr. Wu has developed a holistic approach to cervical cancer treatment, skillfully combining chemotherapy, radiotherapy, and targeted therapy based on each patient’s specific disease characteristics and genetic profile. Her multidisciplinary treatment model has significantly improved survival rates and quality of life for countless women battling advanced or recurrent gynecologic cancers.

On the research front, Dr. Wu has demonstrated remarkable leadership and productivity. She has served as principal investigator for four projects funded by the National Natural Science Foundation of China (NSFC), focusing on topics such as the molecular mechanisms of cervical carcinogenesis, drug resistance in ovarian cancer, and biomarkers for early detection of gynecologic malignancies. Her work has yielded over 50 peer-reviewed papers published in prestigious international SCI-indexed journals, most as first author or corresponding author. These publications cover a wide range of areas including tumor immunology, epigenetic regulation, and personalized medicine, and have been widely cited by researchers worldwide.

In addition to her clinical and scientific contributions, Dr. Wu holds several prominent academic appointments. She is a standing committee member of the Gynecologic Oncology Branch of the Chinese Medical Association and serves on the expert panel of the Chinese Anti-Cancer Association. She regularly delivers invited lectures at national and international conferences, sharing her insights on advances in surgical techniques, chemoradiation protocols, and translational research in gynecologic oncology.

As a mentor, Dr. Wu has supervised numerous master’s and doctoral students, many of whom have gone on to become leaders in their own right. She emphasizes critical thinking, evidence-based practice, and compassionate patient care in her teaching. Her dedication to education has earned her multiple teaching awards and the deep respect of her trainees.

Patients describe Dr. Wu as a physician who combines technical precision with genuine empathy. She takes time to listen to each woman’s story, explains complex diagnoses in understandable language, and involves patients and families in shared decision-making. Her warm bedside manner and unwavering commitment to fighting cancer have made her a trusted figure among those she treats.

Looking ahead, Dr. Wu remains committed to advancing the frontiers of gynecologic oncology through innovative research, refined surgical techniques, and compassionate care. She continues to strive for better outcomes and brighter futures for women facing gynecologic cancers, both in China and around the world.

Dr. Li specializes in the diagnosis and treatment of gynecologic tumors, pelvic floor dysfunction disorders, and all types of minimally invasive gynecologic procedures. Over her career, she has performed over 10,000 minimally invasive gynecologic surgeries​ and more than 5,000 pelvic floor repair operations, making her one of the most experienced surgeons in her field nationally. Her surgical repertoire includes laparoscopic and hysteroscopic procedures for gynecologic malignancies, as well as reconstructive surgeries for uterine prolapse, urinary incontinence, and other pelvic organ prolapse conditions. She has also been invited to demonstrate her surgical techniques at numerous national conferences, sharing her expertise with peers across China.

Academic Leadership & Research

Dr. Li holds prominent academic positions, including National Member of the Pelvic Floor Dysfunction Group of the Chinese Medical Association's Obstetrics and Gynecology Branch, Member of the Shanghai Medical Association's Gynecologic Oncology Branch, Deputy Head of the Shanghai Medical Association's Obstetrics and Gynecology Branch Pelvic Floor Group, and Member of the Shanghai Municipal Gynecologic Quality Control Expert Panel.

Her research focuses on the fundamental mechanisms and clinical optimization of pelvic floor disorders — spanning epidemiology, imaging, anatomy, biomechanics, and surgical technique. She has participated as a key member in the national "12th Five-Year" Science and Technology Support Plan​ and multiple National Natural Science Foundation projects. Currently, she leads a sub-project of the 14th Five-Year Plan Key R&D Program of the Ministry of Science and Technology​ — "Key Technical Research on Fully Degradable Functional Female Pelvic Floor Repair Meshes" — under the parent project "Establishment of Preclinical Evaluation System and Clinical Trials for Fully Degradable Pelvic Floor Repair Meshes." Through collaboration with industry partners, she is driving the development of next-generation pelvic reconstruction materials, bringing China's pelvic floor medicine in line with international frontiers.

Scholarly Output & Mentorship

A prolific researcher, Dr. Li has published over 240 papers​ in domestic and international professional journals, including more than 50 SCI-index papers​ as first or corresponding author. She has co-authored the pelvic floor disease sections of authoritative textbooks such as Practical Obstetrics and Gynecology and Therapeutics in Obstetrics and Gynecology. Her contributions have been recognized with the Shanghai Medical Science and Technology Award​ and the Chinese Maternal and Child Health Science and Technology Award.

As a Ph.D. and Master's supervisor at Tongji University, she has mentored over 50 graduate students, many of whom have gone on to become leaders in their own right. Her accolades include the 2006 Second Prize of the 20th Shanghai Excellent Invention Competition (for the Tong Anterior Suspension Procedure), the 2012 Third Prize of the Shanghai Medical Science and Technology Award, and the 2015 Shanghai Medical Science and Technology Achievement Promotion Award — all for her series of modified female pelvic floor reconstruction surgeries.

Patient Care Philosophy

Beyond her technical mastery, Dr. Li is known for her compassionate, patient-centered approach. She provides specialized and premium outpatient services at Shanghai Tongji Hospital, where she continues to treat complex cases of gynecologic cancer, prolapse, and incontinence. Her 40-year career stands as a testament to the integration of surgical excellence, scientific innovation, and humanistic care — making her a true pioneer in Chinese gynecology.